HELX vs. FLIN
HELX (Franklin Genomic Advancements ETF) and FLIN (Franklin FTSE India ETF) are both exchange-traded funds - HELX is a Health & Biotech Equities fund actively managed by Franklin Templeton, while FLIN is a Asia Pacific Equities fund tracking the FTSE India RIC Capped Index. HELX is actively managed, while FLIN is passively managed. Over the past 5 years, HELX returned -3.93%/yr vs 3.83%/yr for FLIN. At a 0.41 correlation, their price movements are largely independent. HELX charges 0.50%/yr vs 0.19%/yr for FLIN.
Performance
HELX vs. FLIN - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, HELX achieves a -1.55% return, which is significantly higher than FLIN's -10.73% return.
HELX
- 1D
- 3.11%
- 1M
- 5.81%
- YTD
- -1.55%
- 6M
- -4.90%
- 1Y
- 33.84%
- 3Y*
- 5.75%
- 5Y*
- -3.93%
- 10Y*
- —
FLIN
- 1D
- 1.35%
- 1M
- -2.24%
- YTD
- -10.73%
- 6M
- -10.25%
- 1Y
- -10.45%
- 3Y*
- 6.19%
- 5Y*
- 3.83%
- 10Y*
- —
HELX vs. FLIN - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
HELX Franklin Genomic Advancements ETF | -1.55% | 26.34% | -5.32% | 1.14% | -37.89% | 9.80% | 85.05% |
FLIN Franklin FTSE India ETF | -10.73% | 2.40% | 10.33% | 20.58% | -7.96% | 24.96% | 20.48% |
Correlation
The correlation between HELX and FLIN is 0.32, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.32 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.35 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.42 |
Correlation (All Time) Calculated using the full available price history since Feb 28, 2020 | 0.41 |
The correlation between HELX and FLIN shifts across timeframes, from 0.32 (1 year) to 0.42 (5 years), reflecting how their relationship changes across market environments.
HELX vs. FLIN - Sectors Allocation Comparison
Sectors
HELX
FLIN
Healthcare
Basic Materials
Technology
Communication Services
-
Consumer Cyclical
-
Consumer Defensive
-
Energy
-
Financial Services
-
Industrials
-
Real Estate
-
Utilities
-
Healthcare
HELX
FLIN
Basic Materials
HELX
FLIN
Technology
HELX
FLIN
Communication Services
HELX
-
FLIN
Consumer Cyclical
HELX
-
FLIN
Consumer Defensive
HELX
-
FLIN
Energy
HELX
-
FLIN
Financial Services
HELX
-
FLIN
Industrials
HELX
-
FLIN
Real Estate
HELX
-
FLIN
Utilities
HELX
-
FLIN
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
HELX vs. FLIN — Risk / Return Rank
HELX
FLIN
HELX vs. FLIN - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Franklin Genomic Advancements ETF (HELX) and Franklin FTSE India ETF (FLIN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| HELX | FLIN | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +2.32 | ||
| Sortino ratioReturn per unit of downside risk | +3.26 | ||
| Omega ratioGain probability vs. loss probability | 1.28 | 0.89 | +0.38 |
| Calmar ratioReturn relative to maximum drawdown | 1.89 | -0.56 | +2.45 |
| Martin ratioReturn relative to average drawdown | 4.88 | -1.37 | +6.26 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| HELX | FLIN | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 1.61 | -0.70 | +2.32 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | 0.24 | -0.41 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.25 | 0.27 | -0.03 |
Drawdowns
HELX vs. FLIN - Drawdown Comparison
The maximum HELX drawdown since its inception was -58.75%, which is greater than FLIN's maximum drawdown of -41.90%. Use the drawdown chart below to compare losses from any high point for HELX and FLIN.
Loading charts...
Drawdown Indicators
| HELX | FLIN | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.75% | -41.90% | -16.85% |
Max Drawdown (1Y)Largest decline over 1 year | -18.01% | -18.79% | +0.78% |
Max Drawdown (3Y)Largest decline over 3 years | -29.48% | -22.85% | -6.63% |
Max Drawdown (5Y)Largest decline over 5 years | -58.75% | -22.85% | -35.90% |
Current DrawdownCurrent decline from peak | -38.22% | -17.81% | -20.41% |
Average DrawdownAverage peak-to-trough decline | -34.32% | -8.01% | -26.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 6.95% | 7.62% | -0.67% |
Volatility
HELX vs. FLIN - Volatility Comparison
Franklin Genomic Advancements ETF (HELX) has a higher volatility of 7.45% compared to Franklin FTSE India ETF (FLIN) at 5.30%. This indicates that HELX's price experiences larger fluctuations and is considered to be riskier than FLIN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| HELX | FLIN | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.45% | 5.30% | +2.15% |
Volatility (6M)Calculated over the trailing 6-month period | 16.47% | 12.87% | +3.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 21.07% | 14.96% | +6.11% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 24.15% | 15.74% | +8.41% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 27.41% | 20.45% | +6.96% |
HELX vs. FLIN - Expense Ratio Comparison
HELX has a 0.50% expense ratio, which is higher than FLIN's 0.19% expense ratio.
Dividends
HELX vs. FLIN - Dividend Comparison
HELX's dividend yield for the trailing twelve months is around 0.40%, less than FLIN's 0.63% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|---|
FLIN Franklin FTSE India ETF | 0.63% | 0.56% | 1.58% | 0.73% | 0.73% | 2.26% | 0.68% | 0.90% | 0.92% |
HELX Franklin Genomic Advancements ETF | 0.40% | 0.39% | 0.00% | 0.00% | 0.00% | 0.24% | 0.12% | 0.00% | 0.00% |
Frequently Asked Questions
HELX and FLIN have a correlation of 0.32, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
HELX has higher volatility (7.45%) compared to FLIN (5.30%). In terms of maximum drawdown, HELX dropped -58.75% vs FLIN's -41.90%.
On 5-year performance, FLIN leads with 3.83% vs -3.93% for HELX. On fees, FLIN is cheaper at 0.19% per year. On volatility, FLIN has been the lower-risk option at 5.30%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 5-year period, FLIN has performed better with a 3.83% return vs -3.93%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
FLIN is cheaper with a 0.19% expense ratio, compared with 0.50% for HELX.
FLIN has the higher dividend yield at 0.63%, compared with 0.40% for HELX.
HELX is categorized as Health & Biotech Equities, while FLIN is Asia Pacific Equities. Their fees differ too: 0.50% for HELX and 0.19% for FLIN.
HELX currently has the higher Sharpe Ratio (1.61 vs -0.70), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for HELX and FLIN
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer